The SMAD-specific E3 ubiquitin protein ligase 2 (SMURF2) has emerged as a critical regulator in cancer biology, modulating the stability of Hypoxia-Inducible Factor 1-alpha (HIF1α) and influencing a network of hypoxia-driven pathways within the tumor microenvironment (TME). SMURF2 targets HIF1α for …
This lecture is one of the 2025 Senior Vice Chancellor’s Research Seminar series. Speaker Sarah Belcher, PhD, RN, OCN Assistant Professor of Health and Community…
Twelve Pitt faculty members have recently been selected to present their research for the 2025 Senior Vice Chancellor’s Research Seminar Series. This annual lecture series,…
A supply-side reform agenda for one of our most urgent problems
For some time, I’ve been an admirer of many of the articles published on Sensible Medicine, a site that usually features articles written by physicians…
The ISTH 2025 Congress is the premier international medical and scientific conference for experts in the fields of thrombosis, hemostasis and vascular biology. Join us…
El equipo de investigación ‘Terapia celular y nuevas dianas terapéuticas en onco-hematología’ del…
Pancreatic cancer has the worst prognosis of all common tumors. Earlier cancer diagnosis could increase survival rates and better assessment of metastatic disease could improve…
Anna Azvolinsky, PhD, is a freelance medical and science journalist based in New York City. Many phase III cancer clinical trials exclude individuals with absolute…
Ante un caso tan extremo muchos pueden decir que ‘no todos los hombres’ hacen ‘esas cosas’, porque lo monstruoso siempre parece una excepción; pero el…
